Nation's leading experts join forces to accelerate effective treatments for...
The nation's leading brain tumor and biotech industry experts again joined forces Friday, June 7, in a bid to accelerate more effective treatments for brain tumors and promote funding for the latest...
View ArticleResearchers develop method to identify aggressive prostate cancers
Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on...
View ArticleNUS researchers develop highly realistic 3-D tumor model to track progress of...
A team of NUS researchers from the Departments of Bioengineering and Orthopaedic Surgery has developed a highly realistic three-dimensional (3-D) tumour model. As it replicates the conditions in the...
View ArticleSarah Cannon Research Institute opens enrollment in Phase I clinical study...
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that the Sarah Cannon Research Institute in Nashville, Tennessee has opened enrollment in a Phase I clinical study with MORAb-066 in...
View ArticleDecorin protein in blood inhibits tumor progression, say researchers
Researchers from Thomas Jefferson University's Kimmel Cancer Center have discovered that decorin, a naturally occurring protein that circulates in the blood, acts as a potent inhibitor of tumor growth...
View ArticleResearchers develop new drug delivery systems to treat cancer by blocking...
A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study...
View ArticleBayer, Onyx submit sNDA to FDA, marketing authorization application to EMA...
Bayer HealthCare and Onyx Pharmaceuticals today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration and an application for marketing authorization...
View ArticleResearch shows hydrogen sulfide is a key player in colon cancer metabolism
University of Texas Medical Branch at Galveston researchers have discovered that hydrogen sulfide - the pungent-smelling gas produced by rotten eggs - is a key player in colon cancer metabolism, and a...
View ArticleResearchers discover new protein that encourages ‘bad’ blood vessel growth
The discovery of a protein that encourages blood vessel growth, and especially 'bad' blood vessels - the kind that characterise diseases as diverse as cancer, age-related macular degeneration and...
View ArticleCreating, promoting foods containing angiogenesis is the new frontier in...
Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in...
View ArticleASH to award 2013 William Dameshek Prize to Andrew S. Weyrich
The American Society of Hematology will present the 2013 William Dameshek Prize to Andrew S. Weyrich, PhD, of The University of Utah for his seminal research on the cellular and molecular causes of...
View ArticleSevere arthritis pain treatments: an interview with Professor Walsh,...
Pain is defined by the sufferer’s experience. Pain may be severe because it is intense, frequent or sustained, and because it is distressing. The severity of pain is not simply due to what is going on...
View ArticleBioLineRx reports positive results from pre-clinical trials with RHB-104 for...
BioLineRx, a biopharmaceutical development company, announced today that BL-8040 has been shown in pre-clinical trials to be effective for the treatment of thrombocytopenia, or reduced platelet...
View ArticleSignaling protein involved in inflammation also promotes tumor resistance to...
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
View ArticleStudy reveals cancer in humans linked with high amounts of proteins...
Cancer in humans is frequently associated with unusually high amounts of one or more proteins responsible for controlling the rate at which cells divide. As an example, excessive amounts of the...
View ArticleAMSBIO sponsor poster prize at Beatson International Cancer Conference
AMSBIO, a provider of cutting-edge life science technologies and services for accelerating discovery in cancer research, has continued its sponsorship of the annual poster prize at the Beatson...
View ArticleReport demonstrates clinical use of novel biomarker to assess cancer...
A groundbreaking peer reviewed case report by Dr. Isaac Eliaz, M.D. of Amitabha Medical Clinic, demonstrates for the first time the clinical use of novel biomarker galectin-3 to assess cancer...
View ArticleAdvance team of molecules produced by primary tumor is responsible for lung...
Cancer metastasis requires tumor cells to acquire properties that allow them to escape from the primary tumor site, travel to a distant place in the body, and form secondary tumors. But first, an...
View ArticleNew data analyzing technique via MR imaging identify tumors' response to...
A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the...
View ArticleFDA grants Priority Review designation to sNDA for Nexavar tablets
Bayer HealthCare and Onyx Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted Priority Review designation to the supplemental New Drug Application for the oral...
View Article
